| <strong>PICO 16</strong>                                                                           | <strong>MTX: moderate; tofacitinib: low; other medications: indirect evidence only</strong> | PICO 16. Should patients with RMD taking drug Y hold their drug Y for a period of time prior to or after receiving (not live attenuated) vaccines? | 898â€“927                  |